The synthesis and anticancer activity of selected diketopiperazines

Peptides

Volumn 29, Issue 8, 2008, Pages 1305-1311

  van der Merwe, E ^a   Huang, D ^a   Peterson, D ^a   Kilian, G ^a   Milne, P J ^a   Van de Venter, M ^a   Frost, C ^a  

^a NELSON MANDELA METROPOLITAN UNIVERSITY   (South Africa)

Author keywords

Cancer cells; Cyclic dipeptides; HeLa; HT 29; MCF 7

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLO(GLYCYL DEXTRO VALINE); CYCLO(GLYCYLISOLEUCINE); CYCLO(GLYCYLLEUCINE); CYCLO(GLYCYLVALINE); CYCLO(PHENYLALANYLCYSTEINE); CYCLO(TYROSYLCYSTEINE); PIPERAZINEDIONE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CANCER INHIBITION; CELL VIABILITY; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; THIN LAYER CHROMATOGRAPHY; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC AGENTS; CARCINOMA; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIKETOPIPERAZINES; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HELA CELLS; HT29 CELLS; HUMANS; MASS SPECTROMETRY; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR STRUCTURE; NEOPLASMS; PEPTIDES, CYCLIC;

EID: 47649109637     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.03.010     Document Type: Article

References (28)

1. Anteunis M.J.O. The cyclic dipeptides: proper model compounds in peptide research. Bull Chem Soc Belg 87 (1978) 627-650
2. Aulton M.E. Pharmaceutics: the science of dosage form design. 2nd ed. (2002), Churchill Livingstone, UK p. 141-50
3. Bláha K., Smoliková J., and Vitek A. Amino acids and peptides, LXIV. Infrared spectra of substituted 2,5-piperazinediones and the detection of cis-peptide bonds in diastereoisomeric cyclohexapeptides. Collect Czech Chem Commun 31 (1966) 4296-4311
4. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., and Mitchell J.B. Evaluation of tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47 (1987) 936-942
5. Carmichael J. Current issues in cancer: cancer chemotherapy: identifying novel anticancer drugs. Br Med J 308 (1994) 1288-1290
6. Chauhan P.M.S., Martins C.J.A., and Horwell D.C. Synthesis of novel heterocycles as anticancer agents. Bioorg Med Chem 13 (2005) 3513-3518
7. Fischer E. Synthesis von polypeptiden. Chem Ber (1906) 2893-2931
8. Gockel P., Vogler R., Gelinsky M., MeiBner A., Albrich H., and Vahrenkamp H. Zinc complexation of cyclic dipeptides containing cysteine and/or histidine. Inorg Chim Acta 323 (2001) 16-22
9. Grant G.D., Hunt A.L., Milne P.J., Roos H.M., and Joubert J.A. The structure and conformation of the tryptophanyl diketopiperazines cyclo(Trp-Trp) C2H6SO and cyclo(Trp-Pro). J Chem Crystallogr 29 (1999) 435-447
10. Graz C.J.M., Grant G.D., Brauns S.C., Hunt A., Jamie H., and Milne P.J. Cyclic dipeptides in the induction of maturation for cancer therapy. J Pharm Pharmacol 52 (2000) 75-82
11. Jaracz S., Chen J., Kuznetsova L.V., and Ojima I. Recent advances in tumor-targeting anticancer drug conjugates. Bioorg Med Chem 13 (2005) 5043-5054
12. Kanzaki H., Imura D., Nitoda T., and Kawazu K. Enzymatic dehydrogenation of cyclo(L-Phe-L-Leu) to a bioactive derivative, albonoursin. J Mol Catal B: Enzym 6 (1999) 265-270
13. Kopple K.D., and Ghazarian H.G. A convenient synthesis of 2,5 dioxopiperazines. J Org Chem 33 (1968) 862-864
14. Kopple K.D., and Marr D.H. Conformations of cyclic peptides. The folding of cyclic dipeptides containing an aromatic side chain. J Am Chem Soc 89 (1967) 6193-6200
15. Krejcarek G.E., Dominy B.H., and Lawton R.G. The interaction of reactive functional groups along peptide chains. A model for alkaloid biosynthesis. Chem Commun (1968) 1450-1452
16. Lau C., Qin X., Laing J., and Lu J. Determination of cysteine in a pharmaceutical formulation by flow injection analysis with a chemiluminescence detector. Anal Chim Acta 514 (2004) 45-49
17. Lautru S., Gondry M., Genet R., and Pernodet J.-L. The albonoursin gene cluster of S. noursei: biosynthesis of diketopiperazine metabolites independent of nonribosomal peptide synthetases. Chem Biol 9 (2002) 1355-1364
18. Milne P.J., Hunt A.L., Rostoll K., Van der Walt J.J., and Graz C.J.M. The biological activity of selected cyclic dipeptides. J Pharm Pharmacol 50 (1998) 1331-1337
19. Miyazawa T. Normal vibrations of monosubstituted amides in the cis configuration and infrared spectra of diketopiperazines. J Mol Spectrosc 4 (1960) 155-167
20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65 (1983) 55-63
21. Newell D.R. How to develop successful cancer drug-molecules to medicines or targets to treatments. Eur J Cancer 41 (2005) 676-682
22. Ovchinnikov Y.A., and Ivanov V.T. Conformational states and biological activity of cyclic peptides. Tetrahedron 31 (1975) 2177-2209
23. Pachler K.G.R. Nuclear magnetic resonance study of some amino acids. 11. Rotational isomerism. Spectrochim Acta 20 (1964) 581-587
24. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics. CA Cancer J Clin 55 (2005) 74-108
25. Prasad C. Bioactive cyclic dipeptides. Peptides 16 (1995) 151-164
26. Rang H.P., Dale M.M., and Ritter J.M. Pharmacology. 4th ed. (1999), Churchill and Livingstone, United States of America p. 250-56, 663-80
27. Sammes P.G. Naturally occurring 2,5 diketopiperazines and related compounds. Fortschr Chem Organ Naturstoffe 32 (1975) 51-118
28. Vogler R., Gelinsky M., Guo L.F., and Vahrenkamp H. Solution behaviour and zinc complexation of di- and tripeptides with two cysteine units. Inorg Chim Acta 339 (2002) 1-8